Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Emicizumab in Factor 8 Deficiency, Acquired: NCT04188639 Clinical Landscape Report 2026
16 October 2026
NCT04188639 clinical landscape for Factor 8 Deficiency, Acquired: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Denecimig in Hemophilia A: NCT04204408 Clinical Landscape Report 2026
16 October 2026
NCT04204408 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anti-Inhibitor Coagulant Complex (Baxalta US) in Hemophilia A: NCT04205175 Clinical Landscape Report 2026
16 October 2026
NCT04205175 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Voxelotor in Anemia, Sickle Cell: NCT04218084 Clinical Landscape Report 2026
16 October 2026
NCT04218084 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zilucoplan in Myasthenia Gravis: NCT04225871 Clinical Landscape Report 2026
16 October 2026
NCT04225871 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pyridostigmine/Ondansetron in Myasthenia Gravis: NCT04226170 Clinical Landscape Report 2026
16 October 2026
NCT04226170 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LTI-03 in Idiopathic Pulmonary Fibrosis: NCT04233814 Clinical Landscape Report 2026
16 October 2026
NCT04233814 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
AT-702 in Muscular Dystrophy, Duchenne: NCT04240314 Clinical Landscape Report 2026
16 October 2026
NCT04240314 clinical landscape for Muscular Dystrophy, Duchenne: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BLD-2660 in Idiopathic Pulmonary Fibrosis: NCT04244825 Clinical Landscape Report 2026
16 October 2026
NCT04244825 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Voxelotor in Semicircular Canal Dehiscence: NCT04247594 Clinical Landscape Report 2026
16 October 2026
NCT04247594 clinical landscape for Semicircular Canal Dehiscence: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PF-07209326 in Anemia, Sickle Cell: NCT04255875 Clinical Landscape Report 2026
16 October 2026
NCT04255875 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Hydroxycarbamide in Anemia, Sickle Cell: ISRCTN15724013 Clinical Landscape Report 2026
16 October 2026
ISRCTN15724013 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.